Catalyst Wire Dossier Catalyst Wire Dossier

Regulatory T Cell Therapy to Achieve Immunosuppression Reduction

· Singulera Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Regulatory T Cell Therapy to Achieve Immunosuppression Reduction, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: REgulatory T Cell Therapy to Achieve Immunosuppression REduction [Phase 2]

See pricing